DEVELOPMENT OF ACUTE GOUT SECONDARY TO PYRAZINAMIDE IN A PATIENT WITHOUT A PRIOR HISTORY OF GOUT

被引:4
作者
AMODIO, MI
BENGUALID, V
LOWY, FD
机构
[1] MONTEFIORE MED CTR,DEPT MED INFECT DIS,BRONX,NY 10467
[2] MONTEFIORE MED CTR,DEPT MED,BRONX,NY 10467
来源
DICP-THE ANNALS OF PHARMACOTHERAPY | 1990年 / 24卷 / 11期
关键词
D O I
10.1177/106002809002401119
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
引用
收藏
页码:1115 / 1116
页数:2
相关论文
共 5 条
[1]
CULLEN JH, 1956, AM REV TUBERC PULM, V74, P289
[2]
ADVERSE-EFFECTS OF ANTI-TUBERCULOSIS DRUGS [J].
GIRLING, DJ .
DRUGS, 1982, 23 (1-2) :56-74
[3]
RENAL FUNCTION IN GOUT .3. ESTIMATION OF TUBULAR SECRETION AND REABSORPTION OF URIC ACID BY USE OF PYRAZINAMIDE (PYRAZINOIC ACID) [J].
GUTMAN, AB ;
YU, TF ;
BERGER, L .
AMERICAN JOURNAL OF MEDICINE, 1969, 47 (04) :575-+
[4]
STEELE MA, 1988, CHEST, V94, P842
[5]
1989, PACKAGE INSERT PYRAZ